RSV and non-RSV illness hospitalization in RSV immunoprophylaxis recipients: A systematic literature review

RSV Risk: Understanding RSV-Related Hospitalization of High-Risk Infants

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.

OBJECTIVES To systematically review the effectiveness and cost-effectiveness of palivizumab for the prevention of respiratory syncytial virus (RSV) in children and examine prognostic factors to determine whether subgroups can be identified with important differences in cost-effectiveness. DATA SOURCES Bibliographic databases were searched from inception to March 2007 for literature on the eff...

A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.

BACKGROUND Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI) in infants and young children, accounting for approximately 75,000-125,000 hospitalizations per year. It is estimated that in 2000, RSV infection accounted for 1.7 million office visits, 402,000 emergency room visits, and 236,000 hospital outpatient visits per year for children younger th...

RSV immunoprophylaxis: does the benefit justify the cost?

Respiratory syncytial virus (RSV) is among the last viruses to cause major, predictable worldwide outbreaks of disease and for which no vaccine or broadly effective antiviral drug is available. Annually in the United States, RSV accounts for ∼125 000 hospitalizations, 2.1 million outpatient visits to a pediatrician’s office or an emergency department, and 250 deaths among children in the first ...

Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis

OBJECTIVE To identify factors associated with culture-proven serious bacterial infection (SBI) and positive emergency department septic screening (EDSS) tests in children with bronchiolitis and to identify factors associated with the performance of EDSS. METHODS We reviewed an existing study database of patients with bronchiolitis. We defined a positive EDSS as urine with >/=10 WBC per high p...